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OBJECTIVES We examined the hypothesis that mitral annulus calcification (MAC), aortic valve sclerosis
(AVS) and aortic root calcification (ARC) are associated with coronary artery disease (CAD)
in subjects age 65 years.
BACKGROUND Mitral annulus calcification, AVS and ARC frequently coexist and are associated with
coronary risk factors and CAD in the elderly.
METHODS We studied 338 subjects age 65 years who underwent evaluation of chest pain with
myocardial perfusion single photon emission computed tomography (SPECT) and a
two-dimensional transthoracic echocardiogram for other indications. The association of
MAC, AVS and ARC with abnormal SPECT was evaluated by using chi-square analyses and
logistic regression analyses.
RESULTS Compared with no or one calcium deposit and no or one coronary risk factor other than
diabetes, multiple (2) calcium (or sclerosis) deposits with diabetes or multiple (2) coronary
risk factors were significantly associated with abnormal SPECT in women age 55 years old
(odds ratio [OR], 20.00), in women age55 years old (OR, 10.00) and in men age55 years
old (OR, 5.55). Multivariate analyses identified multiple calcium deposits as a significant
predictor for an abnormal SPECT in women (p  0.001), younger subjects age 55 years
(p  0.05) and the total group of subjects (p  0.01).
CONCLUSIONS When coronary risk factors are also taken into consideration, the presence of multiple calcium
deposits in the mitral annulus, aortic valve or aortic root appears to be a marker of CAD in
men 55 years old and women. (J Am Coll Cardiol 2001;38:1988–93) © 2001 by the
American College of Cardiology
Mitral annulus calcification (MAC) and aortic valve sclero-
sis (AVS) represent a degenerative process that progresses
with advancing age (1–4). These calcifications are associ-
ated with coronary risk factors (3–7). Thus, they are also
considered as a manifestation of generalized atherosclerosis
in elderly populations (3,8,9). However, the clinical signif-
icance of these calcifications in a younger population has not
been previously determined. Therefore, we hypothesized
that in subjects age 65 years, MAC, AVS and aortic root
calcification (ARC) would be associated with a higher
prevalence of an abnormal myocardial perfusion single
photon emission computed tomography (SPECT), a
marker of angiographically significant coronary artery dis-
ease (CAD), and that the presence of multiple sites with
calcium deposits (or sclerosis) would infer a greater risk of
CAD.
METHODS
Study subjects. The study is based on analysis of patients
age 65 years who underwent both a two-dimensional
transthoracic echocardiogram (TTE) and a rest/stress myo-
cardial perfusion SPECT at Cedars-Sinai Medical Center
in Los Angeles, California, between 1992 and 1998. Pa-
tients with normal SPECT who had received percutaneous
transluminal angioplasty or coronary bypass graft surgery
were excluded. Of these 338 consecutive patients, there
were 198 men and 140 women (18 to 65 years old, mean age
of 55.3  9.0 years). One hundred thirty-six patients were
age 55 years and 202 patients were age 55 years. The
indication for the TTE was for the assessment of ventricular
or valvular function whereas the SPECT was performed
because of chest pain. The coronary risk factors evaluated at
the time of the SPECT study were diabetes mellitus,
systemic hypertension, hypercholesterolemia, cigarette
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smoking and male gender. Patients with 2 coronary risk
factors were defined to have multiple risk factors. Diabetes
was defined as hyperglycemia requiring previous or on-
going pharmacologic therapy. Hypertension was defined as
either systolic or diastolic elevation of blood pressure
(140/90 mm Hg) or ongoing antihypertensive pharmaco-
logic therapy. Hypercholesterolemia was defined as either a
known treated hypercholesterolemia or a total cholesterol
level of200 mg/dl. Current cigarette smoking was defined
as active smoking within the past 12 months.
SPECT and TTE imaging. Rest thallium-201/stress
technetium-99m sestamibi myocardial perfusion SPECT
was performed as previously described (10,11), using
symptom-limited exercise by the Bruce protocol and aden-
osine stress. Standard reconstruction of SPECT images was
employed with no attenuation correction (12). All stress
imaging employed a combination of supine and prone
imaging to minimize false positive studies (13). Semiquan-
titative visual interpretation of SPECT images was per-
formed with short-axis and vertical long-axis tomograms
divided into 20 segments for each study (10). Each segment
was scored by consensus of two expert observers using a
5-point scoring system (0  normal; 1  equivocal; 2 
moderate; 3  severe reduction of radioisotope uptake; 4 
absence of detectable radiotracer in a segment) without
knowledge of the TTE results. Summed stress score (SSS)
was obtained by means of adding the scores for the 20
segments of the stress sestamibi images. Patients with SSS
4 were considered to have abnormal SPECT (11,14).
Complete TTE studies were performed in all patients with
a commercially available system (Acuson XP/128 and Se-
quoia C256 [Mountain View, California], ATL HDI 5000
[Bothell, Washington], Hewlett-Packard SONOS 1000 or
5500 [Andover, Massachusetts]). The TTE studies were
read by four echocardiologists without knowledge of the
SPECT results. Patients with rheumatic valvular disease,
prosthetic valves or bicuspid aortic valves were excluded
from this study. The TTE criteria for MAC included an
intense echo-producing structure located at the junction of
the atrioventricular groove and posterior mitral valve leaflet
on the parasternal long axis, apical four-chamber or
parasternal short-axis views and was similar to that of Adler
et al. (15). We defined ARC as a focal area of increased
echogenecity and thickening in the aortic root on the
parasternal long-axis view and AVS as a focal area of
increased echogenecity and thickening of the aortic valve
leaflets using the criteria of Stewart et al. (4) and Otto et al.
(16) (Fig. 1). Calcification was graded from 0 to a maximum
of 3 according to the number of anatomic sites involved,
namely at the mitral annulus, the aortic valve and/or the
aortic root. Patients with calcific deposits at two or more of
three locations were defined to have multiple calcium
deposits.
Statistics. Numeric values are given as mean  SD or as a
proportion of the sample size. Student’s t test was used to
compare the baseline interval level data of subjects according
to presence or absence of MAC, AVS or ARC. Chi-square
analysis was used to compare the baseline percent of gender,
risk factors and abnormal SPECT according to the presence
or absence of MAC, AVS or ARC. Mantel-Haenszel tests
were used to assess linear trends with the number of sites
with calcium deposits. Logistic regression analysis was used
to assess the association of abnormal SPECT with multiple
calcium deposits and with coronary risk factors. Data
analysis was performed using the SAS statistical package
(version 6.12).
RESULTS
Baseline characteristics. Factors associated with the pres-
ence of MAC, AVS and ARC based on bivariate analyses
are shown in Table 1. Of the risk factors studied, hyper-
tension (p  0.05) and diabetes mellitus (p  0.05) were
significantly associated with the TTE detected MAC.
Abbreviations and Acronyms
ARC  aortic root calcification
AVS  aortic valve sclerosis
CAD  coronary artery disease
CI  confidence interval
MAC  mitral annulus calcification
OR  odds ratio
SPECT  single photon emission computed tomography
SSS  summed stress score
TTE  transthoracic echocardiogram
Figure 1. Transthoracic echocardiogram showing aortic root calcification (A), mitral annulus calcification (B) and aortic valve sclerosis (C).
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Hypertension (p  0.01), diabetes mellitus (p  0.05) and
a current smoking history (p  0.05) were significantly
more prevalent in the subjects with AVS than those without
AVS. Hypertension was significantly more frequent in
subjects with ARC (p  0.05) (Table 1). Compared with
subjects without calcium deposits, those with MAC (59.1%
vs. 39.5%, p  0.001), AVS (56.7% vs. 43.2%, p  0.05)
and ARC (54.9% vs. 41.5%, p  0.05) had a significantly
higher prevalence of abnormal SPECT. As demonstrated in
Table 2, there was a progressive increase in age (p 0.001),
prevalence of hypertension (p  0.001) and diabetes (p 
0.05) with an increasing number of sites with calcium
deposits. The time interval between TTE and SPECT was
276.1  398.2 days.
The number of sites with calcium deposits and abnormal
SPECT. For the entire cohort of subjects, compared with
patients with no calcium deposits, those with calcium
deposits in two sites had twice the odds of SSS 4 (odds
ratio [OR]  2.12; 95% confidence interval [CI], 1.18 to
3.78; p  0.05) and those with calcium deposits in three
sites had nearly three times the odds of SSS 4 (OR 
2.99; 95% CI, 1.58 to 5.68; p  0.005). In female subjects
with calcium deposits in three sites, the odds of SSS 4
were more than five times that of female subjects with no
calcium deposits (OR  5.14; 95% CI, 1.76 to 15.03; p 
0.005). The odds of SSS 4 were nearly four times that of
subjects with no calcium deposits in subjects age 55 years
with calcium deposits in three sites (OR  3.94; 95% CI,
1.37 to 11.24; p  0.005). As demonstrated in Table 3, in
male patients as well as in the group age55 years there was
no significant difference in identifying patients with abnor-
mal SPECT regardless of the number of sites with calcium
deposits.
Subjects were classified according to the presence of
multiple calcium deposits and the presence of diabetes or
multiple coronary risk factors other than diabetes mellitus.
For the entire group of subjects, compared with no or one
calcium deposit and no or one coronary risk factor other
than diabetes, multiple calcium deposits with diabetes or
multiple coronary risk factors were significantly associated
with abnormal SPECT (OR 4.28; 95% CI, 2.30 to 7.98).
In the subgroup analyses, multiple calcium deposits with
diabetes or multiple coronary risk factors were significantly
associated with abnormal SPECT in men age 55 years
(OR  5.55; 95% CI, 1.59 to 19.38), in women age 55
years (OR  20.00; 95% CI, 2.16 to 184.87) and in women
55 years (OR  10.00; 95% CI, 1.93 to 51.77) (Table 4).
Multiple logistic analyses. As shown in Table 5, multiple
logistic regression analyses were performed for the entire
group of subjects, male subjects, female subjects, subjects
age 55 years and subjects age 55 years. The following
variables were entered into the model: age, gender, diabetes
mellitus, hypertension, hypercholesterolemia, current smok-
ing and multiple calcium deposits. The analyses identified
the multiple calcium deposits (OR  2.08; 95% CI, 1.27 to
3.41; p 0.01), age (OR 1.03; 95% CI, 1.01 to 1.06; p
0.05), male gender (OR  2.85; 95% CI, 1.73 to 4.72; p 
0.001), diabetes mellitus (OR 2.60; 95% CI, 1.50 to 4.49;
p  0.001) and hypercholesterolemia (OR  1.66; 95% CI,
1.03 to 2.67; p  0.05) as significant predictors for the
presence of abnormal SPECT in the total group of subjects.
The multiple calcium deposits (OR 4.88; 95% CI, 1.92 to
12.37; p  0.001) and diabetes mellitus (OR  6.16; 95%
CI, 2.59 to 14.70; p  0.001) were significant predictors in
female subjects. In subjects aged 55 years, the multiple
calcium deposits (OR  2.41; 95% CI, 1.08 to 5.38; p 
Table 2. Baseline Characteristics According to the Number of Sites With Calcium Deposits (or Sclerosis)
No. of Sites With Calcium Deposits
p Value
for Trend
0
(n  80)
1
(n  58)
2
(n  119)
3
(n  81)
Age, yr (mean  SD) 49.5  10.7 56.7  6.7 57.2  7.3 57.3  8.3  0.001
Male 57.5% 62.1% 55.5% 61.7% NS
Hypertension 42.5% 48.3% 63.0% 66.7% 0.001
Hypercholesterolemia 55.0% 44.8% 48.7% 51.9% NS
Diabetes 20.0% 25.9% 30.5% 34.6%  0.05
Current smoking 16.3% 17.2% 18.5% 27.2% NS
NS  not significant.
Table 1. Baseline Characteristics
MAC
(n  176)
No MAC
(n  162)
AVS
(n  157)
No AVS
(n  176)
ARC
(n  206)
No ARC
(n  130)
Age, yr (mean  SD) 56.6  7.8 53.9  9.8† 57.7  7.6 53.0  9.6‡ 57.3  7.6 52.2  10.1‡
Male 55.7% 61.7% 61.8% 55.7% 59.7% 56.9%
Hypertension 63.1% 49.4%* 65.0% 48.3%† 61.7% 48.5%*
Hypercholesterolemia 48.3% 52.5% 49.0% 51.7% 51.5% 49.2%
Diabetes 34.9% 21.0%‡ 33.8% 22.3%* 27.8% 28.5%
Current smoking 18.2% 21.6% 26.1% 14.8%* 22.8% 15.4%
SSS 4 59.1% 39.5%‡ 56.7% 43.2%* 54.9% 41.5%*
*p  0.05. †p  0.01. ‡p  0.001.
ARC  aortic root calcification; AVS  aortic valve sclerosis; MAC  mitral annulus calcification; SD  standard deviation; SSS  summed stress score.
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0.05), diabetes mellitus (OR  3.15; 95% CI, 1.30 to 7.59;
p  0.05) and male gender (OR  2.31; 95% CI, 1.03 to
5.18; p  0.05) were statistically significant predictors of
abnormal SPECT.
DISCUSSION
Although previous studies have shown that MAC, AVS or
ARC are associated with CAD in the elderly (1–4,17), the
significance of cardiac calcification has not been evaluated in
younger subjects. To our knowledge, our study is the first to
demonstrate that: 1) calcium deposits at multiple sites in the
mitral annulus, aortic valve or aortic root are a marker of
CAD in subjects age 65 years, and 2) patients with
multiple calcium deposits and diabetes or multiple coronary
risk factors have about 6 times the odds of abnormal
SPECT in men 55 years old, 20 times in women 55
years old and 10 times in women 55 years old, compared
with those with no or one calcium deposit site and no or one
coronary risk factor other than diabetes. Thus, the presence
of multiple calcium deposits has a significant discriminative
power in identifying CAD when associated with multiple
coronary risk factor or diabetes mellitus.
Coronary risk factors and cardiac calcifications. Mitral
annulus calcification and AVS represent a degenerative
process that occurs mainly in the elderly (1–4). Although
the prevalence of these calcifications increases with age,
several studies suggest that these calcifications are not a
simple degenerative process (3–7). In humans, during ado-
lescence, and the second as well as the third decade of life,
focal yellow deposits that consist of foam cells are observed
in the epicardial coronary arteries as well as on the ventric-
ular surface of the posterior mitral leaflets (8). The disease
process in the aortic valve leaflets of patients with aortic
sclerosis or stenosis has some similarities to that of athero-
sclerosis, which include the process of lipid deposition,
macrophage and T-cell infiltration, and basement mem-
brane disruption (18). Boon et al. (3) suggested that age,
female gender, systemic hypertension, diabetes mellitus and
hypercholesterolemia predispose to MAC. Adler et al. (6)
found that diabetes mellitus and female gender were fre-
quently detected in patients with MAC. The Helsinki
Aging Study showed that hypertension, age and a low body
mass index were independent predictors of AVS; however,
cholesterol, smoking and diabetes mellitus were not predic-
tors (5). In the Cardiovascular Health Study, age, male
gender, hypertension, smoking, lipoprotein (a) and low-
density lipoprotein were independent predictors of AVS (4).
A report by Aronow et al. (7) showed that adults age 62
years with calcified aortic cusps or root had a higher
prevalence of hypercholesterolemia, history of hypertension,
diabetes mellitus and serum high-density lipoprotein level
35 mg/dl than those with normal aortic cusps and root. In
the Framingham Study, the presence of aortic calcified
plaques was most strongly related to hypertension and was
weakly related to other risk factors (17). Although the
significant factors have varied among reports, these reports
show that cardiovascular calcifications are associated with a
high prevalence of coronary risk factors as well as general-
ized atherosclerosis. Diabetes mellitus, hypertension, hyper-
cholesterolemia, cigarette smoking and male gender which
Table 3. Coronary Artery Disease (or Summed Stress Score 4) According to the Number of Sites With Calcium Deposits
(or Sclerosis)
Group
No. of Sites With Calcium Deposits
0 1 2 3
Total 1* 1.16 (0.58–2.31) 2.12 (1.18–3.78)† 2.99 (1.58–5.68)‡
Male 1* 1.49 (0.62–3.58) 2.22 (0.98–4.81) 2.12 (0.93–4.80)
Female 1* 0.51 (0.12–2.19) 2.31 (0.88–6.03) 5.14 (1.76–15.03)‡
Younger (age 55 yrs) 1* 1.13 (0.38–3.32) 2.36 (1.01–5.53)† 3.94 (1.37–11.24)†
Older (age 55 yrs) 1* 0.88 (0.33–2.36) 1.49 (0.63–3.55) 1.94 (0.78–4.4)
*Reference category. †p  0.05. ‡p  0.005. Data are expressed odds ratio (95% confidence interval).
Table 4. Coronary Artery Disease (or Summed Stress Score 4) According to the Multiple Calcium Deposits (or Sclerosis) and DM
or Multiple Risk Factors of Coronary Artery Disease
No Multiple Calcium Deposits Multiple Calcium Deposits
No DM or Multiple
Cardiac Risk Factors
DM or Multiple
Cardiac Risk Factors
No DM or Multiple
Cardiac Risk Factors
DM or Multiple
Cardiac Risk Factors
Total 1* 2.37 (1.17–4.79) 2.59 (1.31–5.1) 4.28 (2.30–7.98)
Male 1* 1.80 (0.75–4.33) 2.25 (0.94–5.37) 2.56 (1.17–5.58)
Older male (age 55 yrs) 1* 1.38 (0.36–5.34) 1.16 (0.35–3.84) 1.13 (0.37–3.43)
Younger male (age 55 yrs) 1* 2.21 (0.65–7.54) 3.40 (0.80–14.44) 5.55 (1.59–19.38)
Female 1* 4.83 (1.12–20.82) 5.06 (1.25–20.42) 13.81 (3.72–51.33)
Older female (age 55 yrs) 1* 1.95 (0.27–13.98) 4.50 (0.81–24.97) 10.00 (1.93–51.77)
Younger female (age 55 yrs) 1* 13.33 (1.28–138.85) 4.00 (0.31–51.03) 20.00 (2.16–184.87)
*Reference category. Data are expressed as odds ratio (95% confidence interval).
DM  diabetes mellitus.
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are commonly associated with cardiac calcifications were the
risk factors evaluated in our study (3–7,17). Our data show
that MAC is associated with a higher prevalence of systemic
hypertension, diabetes mellitus and an older age group.
Patients with AVS are older and had a higher prevalence of
hypertension, diabetes mellitus and current smoking than
those without AVS, and the presence of ARC was associ-
ated with increasing age and hypertension. There is a
greater prevalence of both hypertension and diabetes mel-
litus as the number of sites with calcium deposits increases.
CAD and cardiac calcification. Patients with MAC or
AVS undergoing coronary angiography have a higher prev-
alence of CAD (15,19). In addition, patients with MAC
have a higher incidence of new coronary events than those
without MAC (20,21). Aortic valve sclerosis is associated
with an approximately 50% increase in the risk of cardio-
vascular death or myocardial infarction in adults age 65
years (16). In our study, we utilized abnormal myocardial
perfusion SPECT as a surrogate for angiographically sig-
nificant CAD. Multiple logistic regression analyses revealed
that the multiple calcium deposits remained a statistically
significant predictor for abnormal SPECT, in addition to
conventional coronary risk factors. In the subgroup analyses,
the statistical significance of this observation was main-
tained in women and patients age55 years but not in men
and patients age 55 years. The Framingham Study
showed that aortic calcific plaques are associated with CAD.
But the predictive value of aortic calcific plaques for CAD
generally diminishes with age and a significant increase in
the prevalence of CAD was not found among men age 65
years (17). Adler et al. (6) reported a more prominent
difference in the prevalence of CAD between women with
or without MAC but no significant differences in men.
These studies showed that the risk of CAD associated with
the presence of MAC and ARC was generally stronger in
women than in men. Similarly, our study also showed a
stronger association of calcium deposits with abnormal
SPECT in female and younger age groups. Electron-beam
computed tomography is a sensitive technique for detecting
coronary calcium (22,23). While the prevalence of electron-
beam computed tomography detected calcium increases
markedly with age (23), the specificity to detect obstructive
CAD with electron-beam computed tomography is higher
in the younger patient population (24). In the present study,
the association of multiple calcium deposits with SSS 4
was most evident in female subjects and in male subjects age
55 years with diabetes or multiple coronary risk factors.
Mitral annulus calcification or AVS is known to be more
closely related to age than any other coronary risk factors
(2,3). The findings suggest that multiple calcium deposits,
found in patients 65 years old with diabetes as well as
multiple coronary risk factors, reflect not merely the aging
process but an epiphenomenon of atherosclerosis. As ath-
erosclerosis is a generalized degenerative vascular process,
patients who have more generalized calcium deposits in
these structures are more likely to have atherosclerotic
involvement in the coronary artery, especially in women age
65 years and men age 55 years.
Study limitations. This study was a retrospective study of
patients who underwent both TTE and SPECT for clinical
indications. Consequently, there was a substantial time
interval between the two studies (276.1  398.2 days).
Although atherosclerosis is a chronic disease, some athero-
matous plaques in the coronary artery may have progressed
to a more significant lesion or may even have undergone
plaque rupture and thrombotic occlusion during this time
interval. Such progression over time may affect the associ-
ation of echocardiographic calcium deposits with an abnor-
mal SPECT. As coronary risk factors were evaluated at the
time of the SPECT study, this time interval also may have
affected the prevalence of coronary risk factors at the time of
echocardiographic study. Because of the sample size, there
may not have been sufficient power to demonstrate that
some coronary risk factors were predictive of an abnormal
SPECT. We did not use a digitized method to identify
cardiac calcification. This could have caused a verification
bias and may have affected the reproducibility in identifying
cardiac calcifications. Although the sensitivity and specific-
ity for SSS 4 are high for CAD, there may be a false
positive and false negative diagnosis of CAD with SPECT;
nevertheless, a large body of literature has been developed
supporting the excellent prognostic discrimination of pa-
tients with no CAD or low-risk CAD when SSS 4
compared to patients at higher risk with SSS4 (10,25,26).
Our study did not consider the characteristics of chest pain,
such as typical or atypical angina. The value of cardiac
Table 5. Predictors of Coronary Artery Disease (or Summed Stress Score 4) in Multivariate Analyses
Total
(n  338)
Gender Age, yr
Male
(n  198)
Female
(n  140)
<55
(n  136)
>55
(n  202)
Age 1.03 (1.01–1.06)* 1.04 (1.01–1.08)* 0.99 (0.95–1.05) 1.04 (0.98–1.09) 1.04 (0.94–1.15)
Male 2.85 (1.73–4.72)‡ — — 2.31 (1.03–5.18)* 3.68 (1.88–7.22)‡
Hypertension 0.95 (0.58–1.55) 1.02 (0.54–1.92) 0.65 (0.25–1.49) 1.10 (0.49–2.46) 0.80 (0.42–1.54)
Hypercholesterolemia 1.66 (1.03–2.67)* 1.92 (1.05–3.52)* 1.23 (0.52–2.91) 1.90 (0.85–4.25) 1.57 (0.85–2.89)
Diabetes 2.60 (1.50–4.49)‡ 1.56 (0.73–3.30) 6.16 (2.59–14.70)‡ 3.15 (1.30–7.59)* 2.35 (1.14–4.83)†
Current smoking 1.15 (0.63–2.10) 0.88 (0.45–1.74) 3.08 (0.81–11.67) 2.86 (1.01–8.10)* 0.66 (0.31–1.41)
Multiple calcium deposits 2.08 (1.27–3.41)† 1.50 (0.80–2.81) 4.88 (1.92–12.37)‡ 2.41 (1.08–5.38)* 1.89 (0.99–3.60)
*p  0.05. †p  0.01. ‡p  0.001. Data are expressed as adjusted odds ratio (95% confidence interval).
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calcification in identifying patients with coronary artery
disease may vary according to the presence or characteristics
of the chest pain.
CONCLUSIONS
In the patients with suspected CAD age 65 years, MAC,
AVS and/or ARC on TTE are associated with coronary risk
factors and the presence of multiple sites with calcium
deposits appears to be an independent predictor of an
abnormal myocardial SPECT, an indicator of angiographi-
cally significant CAD. In addition, when multiple coronary
risk factors are present, calcium deposits at two or more of
these sites may help in identifying patients with obstructive
coronary artery disease in men 55 years old and women.
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